Loading…

Moxibustion with different doses for primary dysmenorrhea of cold congelation and blood stasis type: A randomized controlled trial

To explore the clinical effect differences of moxibustion with different doses on primary dysmenorrhea with cold congelation and blood stasis type. A total of 60 patients of primary dysmenorrhea were randomized into an intensified dose group and a conventional dose group. All of the patients were tr...

Full description

Saved in:
Bibliographic Details
Published in:World journal of acupuncture-moxibustion 2021-10, Vol.31 (4), p.275-280
Main Authors: SHI, Wen-ying, LUO, Rong, LIU, Xiao-juan, LIU, Ying-han, CAO, Zhi-liang, ZHANG, Wei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To explore the clinical effect differences of moxibustion with different doses on primary dysmenorrhea with cold congelation and blood stasis type. A total of 60 patients of primary dysmenorrhea were randomized into an intensified dose group and a conventional dose group. All of the patients were treated with moxibustion. In the intensified dose group, the treatment was given three times daily (once every morning, afternoon and at bedtime successively) and during the trial, 1 case was dropped out and 29 cases were included in the statistical analysis finally. In the conventional dose group, the treatment was given once daily and 1 case was dropped out during trial and 29 cases were included in the statistical analysis. The score of visual analogue scale (VAS) at the worst painful time point, the score of dysmenorrhea symptoms and recurrence rate were observed and compared before and after treatment in the patients between the two groups. The clinical therapeutic effects were observed in the two groups too. VAS difference value (D-value) and dysmenorrhea symptoms D-valuebefore and after treatment in the intensified dose group were higher than those in the conventional dose group respectively (both P 
ISSN:1003-5257
DOI:10.1016/j.wjam.2021.07.004